Where’s Next for Public Health ROI Research?
The return on investment (ROI) research in public health is evolving as a useful ingredient to the decision-making process, but a number of challenges exist currently. This chapter surveys these challenges. The barriers to use ROI tools are around commissioning contexts, local needs, target population and types of users. Like any other model, ROI models are not free from limitations. Methodological research for the future could look at the ways in which more accurate data around effects (health, quality of life and wider) of behaviour change could be collected. Also, more accurate modelling techniques such as the one allowing individual user-level variation may be required. Transferring a well-established ROI model to other jurisdictions or other areas of public health may save research resources.
KeywordsDecision making Return on investment ROI Impact Stakeholder
- 2.EQUIPT. Supporting decision making in tobacco cessation in Europe: Tobacco Control Policy Proposals. 2016. http://equipt.eu/deliverables
- 3.Public Health England (PHE). Making the case for investment in prevention and early intervention: tools and frameworks to help local authorities and the NHS. London: Public Health England; 2014.Google Scholar
- 4.Gibbon M. Kent Tobacco Control and Stop Smoking Strategy. Kent County Council; 2014. http://democracy.tunbridgewells.gov.uk/meetings/documents/s11642/Tobacco%20Control%20in%20Kent.pdf
- 6.Cheung K, Evers S, de Vries H, Hiligsmann M. The most important barriers and facilitators to the use of HTA by policy makers. Eur Health Psychol. 2016;18(Suppl):477.Google Scholar
- 8.National Institute for Health and Care Excellence (NICE). Return on investment tools. 2016. https://www.nice.org.uk/About/What-we-do/Into-practice/Return-on-investment-tools
- 9.EQUIPT. European-study on Quantifying Utility of Investment in Protection from Tobacco. 2016. http://www.equipt.eu/
- 10.World Health Organisation (WHO). WHO OneHealth Tool. WHO. 2014.Google Scholar
- 17.Rutter J. Evidence and evaluation in policy making. London: Institute for Government; 2012.Google Scholar
- 18.Vokó Z, Cheung KL, Józwiak-Hagymásy J, Wolfenstetter S, Jones T, Muñoz C, et al. Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey. Health Res Policy Syst. 2016;14(1):38.CrossRefGoogle Scholar